EMIS 2017 final results
Operational highlights - strong financial position and underlying growth
· The Group continues to be financially strong, completing 2017 with recurring revenues up 4% representing 83% of total revenues, a net cash position of £14m and access to debt facilities of up to £60m
· Excluding £3.5m of new investment into Patient during the year, adjusted operating profit improved by 5%
· Legacy issues being proactively managed with NHS Digital, with an £11.2m provision made to cover potential financial settlement and costs to remedy past issues
· Progressive dividend policy maintained, with a 10% increase versus last year and total payments to shareholders of over £15m in 2017